National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 21,745 cases where Vaccine targets COVID-19 (COVID19) and Patient Died

Government Disclaimer on use of this data



Case Details

This is page 1298 out of 2,175

Result pages: prev   1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307   next


VAERS ID: 1265803 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-24
Onset:2021-03-07
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-04-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP9568 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: C-reactive protein, C-reactive protein increased, Computerised tomogram thorax, Pneumonia, Respiratory failure
SMQs:, Anaphylactic reaction (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Eosinophilic pneumonia (broad), Hypersensitivity (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Hypokalaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-15
   Days after onset: 7
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: PREDNISOLONE; ZYTIGA; GOSERELIN
Current Illness: Bone metastases; Brain metastases; Carcinoma of lung; Metastases to lymph nodes; Prostate cancer metastatic; Skin metastases
Preexisting Conditions: Medical History/Concurrent Conditions: Cancer
Allergies:
Diagnostic Lab Data: Test Date: 202011; Test Name: CT lung; Result Unstructured Data: Test Result:Lung changes visible. The lung changes were not...; Comments: Lung changes visible. The lung changes were not biopsied, but probable lung metastases/carcinomatosis.; Test Date: 20210307; Test Name: C-reactive protein; Result Unstructured Data: Test Result:Increased
CDC Split Type: NOPFIZER INC2021447072

Write-up: RESPIRATION FAILURE; suspected pneumonia; Increased C-reactive protein; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number NO-NOMAADVRE-FHI-2021-Ueewq9. An 85-year-old male patient received bnt162b2 (COMIRNATY), dose 2 intramuscular on 24Feb2021 (Batch/Lot Number: EP9568) as single dose for COVID-19 immunization. Medical history included ongoing carcinoma of lung, ongoing prostate cancer metastatic (Advanced and aggressive prostate cancer with spread to skeleton, lungs, paraaortic lymph nodes, subcutaneous lesions and to brain), ongoing skeleton metastases, ongoing paraaortic lymph nodes metastases, ongoing metastatic subcutaneous lesions, ongoing brain metastases and cancer. Concomitant medication included prednisolone, abiraterone acetate (ZYTIGA) and goserelin (GOSERELIN) taken for cancer. The patient previously took first dose of bnt162b2 (COMIRNATY) on an unspecified date for COVID-19 immunization. On 07Mar2021, the patient was acutely admitted to hospital with respiratory failure 11 days after vaccination with the second dose of covid-19 vaccine (Comirnaty). Pneumonia was suspected. Increased C-reactive protein. Treated with antibiotics without response. The patient''s condition worsened and required ventilatory support. The patient got CPAP/BiPAP without improvement of the situation. The patient died 19 days after vaccination with the second dose. Multimorbid patient with advanced and aggressive prostate cancer with metastases to the skeleton, lungs, paraaortic lymph nodes, subcutaneous lesions and to the brain. The reporter and colleagues consider that the probable cause of the death is increasing cancer-related pulmonary carcinoma which led to the lung failure. The physician still chooses to report the condition as a possible side effect, according to the relatives'' wishes. The patient died on 15Mar2021. An autopsy was not performed. Reporter''s comments: Hospitalized 07Mar2021. Pneumonia was suspected. Increased C-reactive protein. Treated with antibiotics without response. The patient''s condition worsened and required ventilatory support. The patient got CPAP/BiPAP without improvement of the situation. He died with family members present. No autopsy, due to the patients wish. The relatives are of the opinion that covid-19 vaccination (second dose) is the basis for the patients lung condition and death. The patient was widely discussed between colleagues at the hospital. Pneumonitis is not a known side effect of medications the patient was treated with. The reporter and colleagues consider that the probable cause of the death is increasing cancer-related pulmonary carcinoma which led to the lung failure. The physician still chooses to report the condition as a possible side effect, according to the relatives'' wishes. Prostate cancer not treated with chemotherapy.; Reported Cause(s) of Death: RESPIRATION FAILURE; suspected pneumonia; Increased C-reactive protein


VAERS ID: 1265804 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-25
Onset:2021-04-12
   Days after vaccination:46
Submitted: 0000-00-00
Entered: 2021-04-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP2166 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Blood pressure systolic, Blood pressure systolic increased, Cerebral haemorrhage, Fatigue, Headache
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Hypertension (narrow), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-14
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210412; Test Name: Blood pressure systolic; Result Unstructured Data: Test Result:220 mmHg; Comments: Measured by the GP; Test Date: 20210412; Test Name: Blood pressure systolic; Result Unstructured Data: Test Result:150 mmHg; Comments: Blood pressure measured on arrival hospital
CDC Split Type: NOPFIZER INC2021453500

Write-up: CEREBRAL HEMORRHAGE; new-onset headaches and was very tired and exhausted; new-onset headaches and was very tired and exhausted; blood pressure systolic: 220 mmhg on 12Apr2021 (Measured by the GP), and 150 mmhg on 12Apr2021 (Blood pressure measured on arrival at hospital).; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number NO-NOMAADVRE-FHI-2021-Uxz3gm. An 85-year-old female patient received the second dose of BNT162B2 (COMIRNATY, Lot Number: EP2166) intramuscularly on 25Feb2021 at single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient had previously received the first dose of BNT162B2 (COMIRNATY, batch number unknown) on 04Feb2021 for COVID-19 vaccination. On 12Apr2021, the patient developed cerebral hemorrhage. Relevant laboratory findings and investigations included blood pressure systolic: 220 mmHg on 12Apr2021 (Measured by the GP), and 150 mmHg on 12Apr2021 (Blood pressure measured on arrival at hospital). The primary reporter stated that she was unsure of the causal link between vaccination and cerebral hemorrhage and pointed out that for this patient a hypertensive hemorrhage was also a possibility. The doctor further wrote that the patient after vaccination (2021) experienced new-onset headaches and was very tired and exhausted. The condition became acutely worse on 12Apr2021 and the patient was hospitalized on 12Apr2021. The patient died on 14Apr2021 for cerebral hemorrhage. It was not reported if an autopsy was performed. The outcome of other events was unknown. The case was considered to be Serious. The Regulatory Authority has assessed the causal relationship between the suspect product and the cerebral hemorrhage as Possible. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: CEREBRAL HEMORRHAGE


VAERS ID: 1265805 (history)  
Form: Version 2.0  
Age: 77.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-28
Onset:2021-01-01
Submitted: 0000-00-00
Entered: 2021-04-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM0477 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: C-reactive protein, Cerebrovascular accident, Death, Fall, Illness, Moaning, Unresponsive to stimuli
SMQs:, Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-03
   Days after onset: 33
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: SOBRIL; METOPROLOL SANDOZ [METOPROLOL SUCCINATE]; ESOMEPRAZOL PENSA
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cerebral bleeding (reduced function (one-sided),misalignment in one foot and reduced force/power); Chronic hepatic failure (Due to previous alcoholism.); Emotional disturbance NOS; Ex-alcoholic; Heartburn; Hypertension; Living in residential institution (Resident in a 24-hour staffed home.); Malignant neoplasm of prostate; Musculoskeletal malfunction arising from mental factors; Nausea; Pale skin; Urinary tract infection; Vascular dementia (Vascular dementia gradually developed.); Weakness; Yellow skin
Allergies:
Diagnostic Lab Data: Test Date: 20210127; Test Name: C-reactive protein; Result Unstructured Data: Test Result:51 mg/l; Comments: elevated
CDC Split Type: NOPFIZER INC2021453496

Write-up: suspected stroke; groaning/moaning; no verbal contact; DEATH; Fall; became ill; This is a spontaneous report from a contactable other hcp downloaded from a regulatory authority-WEB, regulatory authority number NO-NOMAADVRE-FHI-2021-Uyj4e2. A 77-year-old male patient received bnt162b2 (COMIRNATY), dose 2 intramuscularly administered in arm left on 28Jan2021 (Lot Number: EM0477) at vaccination age of 77 years old at 0.3 mL single for covid-19 immunisation. Medical history included chronic hepatic failure (due to previous alcoholism), prostate cancer, living in residential institution (resident in a 24-hour staffed home), cerebral haemorrhage from 2013 (with reduced function (one-sided), including misalignment in one foot and reduced force/power, he walked on his own, no aids), vascular dementia, ex-alcoholic, somatic symptom disorder from 2013, emotional disorder, hypertension, dyspepsia, Gradually weakened, nausea, yellow and pale skin, small infections (like urinary tract infection). Concomitant medications included oxazepam (SOBRIL) taken for emotional disorder; metoprolol succinate (METOPROLOL SANDOZ) taken for hypertension; esomeprazole sodium (ESOMEPRAZOL PENSA) taken for dyspepsia. The patient had previously received the first dose of bnt162b2 (COMIRNATY) on 07Jan2021 at single dose for covid-19 immunisation. The patient died six days after vaccination with covid-19 vaccine, second dose. Observed for 30 minutes after the vaccine. He then fell on his way back to his room. He got up on his feet again, with help. A few days passed without anything special and he went with his wife on a car trip. Then he became ill after a couple of days. Three days after the vaccination he was sitting in a chair groaning/moaning, leaned over to the right side and with open eyes, but with no verbal contact. Hospitalized with suspicion of stroke. He received thrombolysis without improvement. He was discharged to the residential institution the next day, with a focus on palliative care. He had slightly elevated CRP the recent time, and it was elevated the day before the second dose. Relatives wanted to report this event for research purposes. No information obtained about the cause of death registered in the death certificate. The patient died on 03Feb2021. It was not reported if an autopsy was performed. The patient underwent lab tests and procedures which included c-reactive protein: 51 mg/l (upper normal limit 4 mg/l) on 27Jan2021. The outcome of events suspected stroke, groaning/moaning and no verbal contact was not recovered. The outcome of events fall and illness was unknown. The regional pharmacovigilance center assessed the causal relationship between the suspect product and death as possible. Reporter''s comments: Observed for 30 minutes after the vaccine. He then fell on his way back to his room. He got up on his feet again, with help. A few days passed without anything special and he went with his wife on a car trip. Then he became ill after a couple of days. Three days after the vaccination he was sitting in a chair groaning/moaning, leaned over to the right side and with open eyes, but with no verbal contact. Hospitalized with suspicion of stroke. He received thrombolysis without improvement. He was discharged to the residential institution the next day, with a focus on palliative care. Relatives wanted notification for research purposes. During the whole winter: Gradually weakened, with nausea, yellow and pale skin and small infections (like urinary tract infection). The municipal chief physician was asked if the patient could receive the vaccine. No follow-up attempts are possible. No further information is expected. ; Reporter''s Comments: RELIS: We have not been able to get hold of information (through contacting the reporter) about the registered cause of death in the death certificate.; Reported Cause(s) of Death: DEATH


VAERS ID: 1265806 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-16
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER7812 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain, Asthenia, Body temperature, Condition aggravated, Cough, Death, Diarrhoea, Hyperhidrosis, Oxygen saturation decreased, PCO2 abnormal, Pyrexia, Renal failure, SARS-CoV-2 test
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Anaphylactic reaction (broad), Acute pancreatitis (broad), Lactic acidosis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Pseudomembranous colitis (broad), Acute central respiratory depression (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Eosinophilic pneumonia (broad), Chronic kidney disease (narrow), Noninfectious diarrhoea (narrow), Tumour lysis syndrome (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-16
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: Temperature; Result Unstructured Data: Test Result:38 degrees Celsius; Test Name: COVID test; Result Unstructured Data: Test Result:negative; Test Name: COVID test; Result Unstructured Data: Test Result:positive (repeat test)
CDC Split Type: PLPFIZER INC2021448064

Write-up: saturation decreased; kidneys stopped functioning; did not excrete CO2; cough; fever; Diarrhea; abdominal pain; sweating; weakness; condition worsened; patient died; The initial case was missing the following minimum criteria: adverse event. Upon receipt of follow-up information on 22Apr2021, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received the first dose of bnt162b2 (COMIRNATY; Lot Number: ER7812), via an unspecified route of administration on 16Mar2021 at a single dose for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. It was reported at first that the husband felt well. Later cough appeared, that was intensifying every day. After about 2 weeks following events occurred: fever, diarrhea, abdominal pain, sweating, intense cough, weakness. After fever reached 38 degrees Celsius both reporter and her husband took COVID test. The reporter received positive results , while her husband received negative result. A physician recommended to repeat the test to the husband. After repeat test the result was positive. Later the condition of the patient worsened day by day. Patient''s saturation was decreasing so the reporter called an ambulance. The patient was admitted to a hospital. In the hospital he was hooked up to a respirator. The patient was under respirator 6-7 days. Then the patient''s kidneys stopped working, he was not excreting C02, but after 2-3 days kidneys started to work again, patient was excreting C02 again. He was unplugged from the respirator and transferred onto internal medicine unit where he was for 7 days. He died on 16Apr2021. The patient underwent lab tests and procedures which included body temperature: 38 degrees celsius on an unspecified date, sars-cov-2 test: negative on an unspecified date and sars-cov-2 test: positive (repeat test) on an unspecified date. The patient died on 16Apr2021. It was not reported if an autopsy was performed. The outcome of kidneys stopped functioning and did not excrete co2 was recovered on an unspecified date while other events were unknown.; Reported Cause(s) of Death: Unknown cause of death


VAERS ID: 1265809 (history)  
Form: Version 2.0  
Age: 88.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-18
Onset:2021-03-25
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-04-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET3674 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Brain stem stroke
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: PLPFIZER INC2021447038

Write-up: Brain stem stroke resulted in the death; This is a spontaneous report from a contactable consumer downloaded from a regulatory authority-WEB (regulatory authority number: PL-URPL-DML-MLP.4401.2.235.2021). An 88-year-old female patient received the first dose bnt162b2 (COMIRNATY, Solution for injection, lot number: ET3674), intramuscular on 18Mar2021 (received at 88-years-old) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced brain stem stroke resulted in the death on 25Mar2021. The patient was hospitalized for brain stem stroke resulted in the death for 6 days. The patient died on an unspecified date. It was not reported if an autopsy was performed. The reporter did not assess the severity of the event. Basing on the nature of adverse events, hospitalization (6 days) and death of the patient, classified this report as serious. Sender''s Comments: Comirnaty is a mRNA vaccine against COVID-19 (nucleoside modified) Reported adverse event has not so far in this term been listed in a regulatory authority. Up until 13Mar2021 in the database, in association with administration of Comirnaty, 1 brain stem stroke case (brain stem stroke) and 655 cases under HLT: Central nervous system haemorrhages and cerebrovascular accidents. Temporal relation suggest causality. The reporter did not assess the severity of the event. Basing on the nature of adverse events, hospitalization (6 days) and death of the patient, classified this report as serious. No follow-up attempts possible. No further information expected. ; Reported Cause(s) of Death: brain stem stroke resulted in the death


VAERS ID: 1265821 (history)  
Form: Version 2.0  
Age: 80.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-31
Onset:2021-03-31
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2239 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Cerebrovascular accident, Condition aggravated, Fatigue, Pneumonia aspiration
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-08
   Days after onset: 8
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Pacemaker insertion (cardiac) (At 45 years old)
Allergies:
Diagnostic Lab Data:
CDC Split Type: PTPFIZER INC2021447263

Write-up: Stroke; Aspiration pneumonia; Tiredness aggravated; Tiredness aggravated; This is a spontaneous report from a contactable consumer, the patient''s daugther. An 80-years-old female patient received bnt162b2 (COMIRNATY), dose 2 on 31Mar2021 at 14:00 (Batch/Lot number EW2239) as 0.3 mL, single for covid-19 immunisation. Medical history included cardiac pacemaker insertion in 19Nov1985 (at 45 years old). The patient''s concomitant medications were not reported. The patient previously received bnt162b2 (COMIRNATY), dose 1 on 3Mar2021 at 15:00 and complained of vaccination site pain (left arm) and tiredness, which persisted until intake of dose 2. Following administration of dose 2, the patient experienced tiredness aggravation at the end of 31Mar2021, persisting until 2Apr2021. On the dawn of 3Apr2021, the patient experienced an extensive stroke (right side), detected on early morning. The patient was hospitalized with reserved prognosis due to lesions from stroke and pulmonar lesions - aspiration pneumonia, occurred as a consequence of stroke. The patient died on 8Apr2021 at 10:00 (at 80 years old). The patient died on 08Apr2021. It was not reported if an autopsy was performed. The reported cause of death was stroke and pulmonar lesions - aspiration pneumonia. Follow up information has been requested.; Sender''s Comments: Linked Report(s) : PT-PFIZER INC-2021448703 Events experienced following dose 1; Reported Cause(s) of Death: Extensive stroke; Aspiration pneumonia


VAERS ID: 1266191 (history)  
Form: Version 2.0  
Age: 90.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-01
Onset:2021-03-03
   Days after vaccination:30
Submitted: 0000-00-00
Entered: 2021-04-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-03
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: No medical history was reported by the reporter.
Allergies:
Diagnostic Lab Data:
CDC Split Type: FIMODERNATX, INC.MOD20210

Write-up: Sudden death; This regulatory authority case was reported by a consumer and describes the occurrence of SUDDEN DEATH (Sudden death) in a 90-year-old male patient who received mRNA-1273 (COVID 19 Vaccine Moderna) for COVID-19 vaccination. No medical history was reported by the reporter. In February 2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (unknown route) 1 dosage form. The patient died on 03-Mar-2021. The cause of death was not reported. It is unknown if an autopsy was performed. The action taken with mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable. Company comment: Limited information regarding the death of this elderly man has been provided at this time and a causal relationship cannot be excluded; Reported Cause(s) of Death: Unknown cause of death


VAERS ID: 1266206 (history)  
Form: Version 2.0  
Age: 77.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-05
Onset:2021-04-05
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 3001442 / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-05
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: EUTIROX; ATENOLOLO EG; LASIX [FUROSEMIDE]; COAPROVEL; HUMALOG
Current Illness: Artificial cardiac pacemaker wearer; Diabetes mellitus; Hypertension; Hyperthyroidism
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITMODERNATX, INC.MOD20210

Write-up: This regulatory authority case was reported by a physician and describes the occurrence of SUDDEN DEATH in a 77-year-old female patient who received mRNA-1273 (COVID 19 Vaccine Moderna) (batch no. 3001442) for COVID-19 vaccination. Concurrent medical conditions included Diabetes mellitus, Hypertension, Hyperthyroidism and Artificial cardiac pacemaker wearer. Concomitant products included LEVOTHYROXINE SODIUM (EUTIROX), ATENOLOL (ATENOLOLO EG), FUROSEMIDE (LASIX [FUROSEMIDE]), HYDROCHLOROTHIAZIDE, IRBESARTAN (COAPROVEL) and INSULIN LISPRO (HUMALOG) for an unknown indication. On 05-Apr-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form. The patient died on 05-Apr-2021. The cause of death was not reported. It is unknown if an autopsy was performed. For mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular), the reporter did not provide any causality assessments. Action taken with mRNA-1273 in response to the events was not Applicable. treatment information not provided. Company comment:Limited information regarding the event has been provided at this time and a causal relationship cannot be excluded. Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Minor change to name of Concomitant medication from Lasix vials to Lasix tablets; Sender''s Comments: Limited information regarding the event has been provided at this time and a causal relationship cannot be excluded; Reported Cause(s) of Death: Unknown cause of death


VAERS ID: 1268442 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-02
Onset:2021-03-01
   Days after vaccination:27
Submitted: 0000-00-00
Entered: 2021-04-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6797 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Acute kidney injury, Asymptomatic COVID-19, Renal failure, SARS-CoV-2 test, Vaccination failure
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Lack of efficacy/effect (narrow), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Chronic kidney disease (narrow), Tumour lysis syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Dehydration (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-17
   Days after onset: 46
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CARVEDILOL; VALSARTAN; FUROBEXAL; THYREX; SPIRONO; TRAMADOL HCL RET; ZINKOROTAT
Current Illness: Atrial fibrillation (atrial fibrillation under Marcoumar); Cardiac insufficiency (heart insufficiency); Chronic renal insufficiency (Chronic renal insufficiency, acute to chronic renal insufficiency Mar2021); Hypertension arterial (Hypertension arterial); Lung nodule (round lesion on the right lower lobe since 2012); Strumectomy (Strumectomy - substitution hypothyroidism)
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210401; Test Name: SARS-CoV-NPS-PCR; Result Unstructured Data: Test Result:positiv, Cycle threshold value 22; Comments: positiv, Cycle threshold value 22; Test Date: 20210408; Test Name: SARS-CoV-NPS-PCR; Result Unstructured Data: Test Result:positiv, Cycle threshold value 24; Comments: positiv, Cycle threshold value 24; Test Date: 20210413; Test Name: SARS-CoV-NPS-PCR; Result Unstructured Data: Test Result:negativ; Comments: negativ; Test Date: 20210415; Test Name: SARS-CoV-NPS-PCR; Result Unstructured Data: Test Result:positiv, Cycle threshold value 26; Comments: positiv, Cycle threshold value 26
CDC Split Type: ATPFIZER INC2021453709

Write-up: Asymptomatic COVID-19, Covid positiv PCR cycle threshold value 22; no typical covid symptoms; exacerbation of chronic renal failure; exacerbation of chronic renal failure/Acute renal failure; This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB, regulatory authority number AT-BASGAGES-2021-23201. A 90-year-old female patient received bnt162b2 (COMIRNATY), dose 2 intramuscular on 02Feb2021 (Batch/Lot Number: EJ6797; Expiration Date: 30Apr2021) as single dose, and dose 1 via an unspecified route of administration on 13Jan2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included ongoing atrial fibrillation under Marcoumar, Lung nodule from 2012 (round lesion on the right lower lobe), thyroidectomy (Strumectomy - substitution hypothyroidism), cardiac failure (heart insufficiency), chronic renal insufficiency and hypertension arterial; all ongoing. Concomitant medications included carvedilol from 18Jun2020 to 17Apr2021; valsartan taken for cardiac disorder from an unspecified start date to 15Apr2021; furosemide (FUROBEXAL) taken for polyuria from 2017 to an unspecified stop date; levothyroxine sodium (THYREX) taken for hypothyroidism from 14Feb2017 to an unspecified stop date; spironolactone (SPIRONO) taken for polyuria from 2017 to an unspecified stop date; tramadol hcl (TRAMADOL HCL RET) taken for an unspecified indication from Feb2017 to an unspecified stop date; zinc orotate (ZINKOROTAT) taken for an unspecified indication from 06Apr2021 to an unspecified stop date. The patient experienced exacerbation of chronic renal failure and acute renal failure on Mar2021, no typical covid symptoms (such as fever, cough / shortness of breath, sore throat, nausea / vomiting, muscle or joint pain or headache) and covid positiv pcr cycle threshold value 22 on 01Apr2021. The patient underwent lab tests and procedures which included SARS-CoV-NPS-PCR: positiv, cycle threshold value 22 on 01Apr2021, positiv, cycle threshold value 24 on 08Apr2021 positiv, negativ on 13Apr2021, and cycle threshold value 26 on 15Apr2021 positiv. Patient was home quarantine from 03Apr2021 to 15Apr2021. The patient died on 17Apr2021 due to exacerbation of chronic kidney failure and acute renal failure. An autopsy was not performed. Events no typical covid symptoms and covid positiv pcr cycle threshold value 22 was not recovered. No follow-up attempts needed. No further information is expected.; Reported Cause(s) of Death: exacerbation of chronic kindey failure; acute renal failure


VAERS ID: 1268462 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-09
Onset:2021-04-12
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-04-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Dyspnoea, Malaise, Pulmonary embolism, Vomiting
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-04-14
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arterial hypertension; Mental retardation; Psychosis
Allergies:
Diagnostic Lab Data:
CDC Split Type: DEPFIZER INC2021431565

Write-up: sudden vomiting at home; Malaise; Dyspnoea; reanimation with suspected lung embolism, patient died; This is a spontaneous report from a non-contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number DE-PEI-202100035456. A 39-years-old male patient received BNT162B2 (COMIRNATY, Solution for Injection, Lot Number: Unknown), via an unspecified route of administration on 09Apr2021 as 0.3 mL, single dose for COVID-19 immunisation. The patient''s medical history included psychosis, mental retardation and arterial hypertension. Concomitant medications were not reported. On an unspecified date, the patient experienced sudden vomiting at home, with malaise and dyspnoea, which led to hospitalization. On 12Apr2021, the patient experienced reanimation with suspected lung embolism in the hospital. Therapeutic measures with clozapin were taken as a result of reanimation with suspected lung embolism, not verified. Patient died on 14Apr2021 due to lung embolism. It was not reported if an autopsy was performed. The reporter reported this report as serious - death, hospitalization, life threatening. Outcome of the event lung embolism was fatal. Outcome of all other events was unknown. No follow-up attempts needed, follow-up automatically provided by Regulatory Authority. ; Reported Cause(s) of Death: reanimation with suspected lung embolism, patient died


Result pages: prev   1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=1298&VAX=COVID19&VAXTYPES=COVID-19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166